Vijay Pande Contributor Share on Twitter Vijay Pande, PhD, is a general partner at Andreessen Horowitz, as well as an Adjunct Professor of Bioengineering at Stanford University, where he continues to advise the Pande Lab — focused on tackling challenging problems in chemical biology, biophysics, and biomedicine. Everything we do in the $3 trillion healthcare […]
View More Consumer-focused healthcare can save lives by focusing on changing behaviorCategory: Disease
Healthcare by 2028 will be doctor-directed, patient-owned and powered by visual technologies
Evan Nisselson Contributor Evan Nisselson is a partner at LDV Capital. More posts by this contributor Deep learning with synthetic data will democratize the tech industry The war over artificial intelligence will be won with visual data Visual assessment is critical to healthcare – whether that is a doctor peering down your throat as you […]
View More Healthcare by 2028 will be doctor-directed, patient-owned and powered by visual technologiesHealthcare wearables level up with new moves from Apple and Alphabet
Announcements that Apple has partnered with Aetna health insurance on a new app leveraging data from its Apple Watch and reports that Verily — one of the health-focused subsidiaries of Google‘s parent company — Alphabet, is developing a shoe that can detect weight and movement, indicate increasing momentum around using data from wearables for clinical health applications and […]
View More Healthcare wearables level up with new moves from Apple and AlphabetAiming to change the way people take medicine, Lyndra Therapeutics raises $55 million
A little over two years after Lyndra Therapeutics Inc. first unveiled its technology for time-delayed drug delivery through a simple pill, the company has raised $55 million to continue developing the technology for public consumption. By creating a new kind of ultra long-acting drug delivery mechanism in pills, the company claims it can remove the […]
View More Aiming to change the way people take medicine, Lyndra Therapeutics raises $55 millionUp to $818 million deal between J&J and Locus Biosciences points to a new path for CRISPR therapies
The up to $818 million deal between Locus Biosciences and Janssen Pharmaceuticals (a division of Johnson & Johnson) that was announced yesterday points toward a new path for CRISPR gene editing technologies and (potentially) the whole field of microbiome-targeted therapies. Based in Research Triangle Park, N.C., Locus is commercializing research initially developed by scientists at […]
View More Up to $818 million deal between J&J and Locus Biosciences points to a new path for CRISPR therapiesCompanies tracking mutations in cancer cells can provide a key to unlocking better therapies
Investors and entrepreneurs are beginning to bring new diagnostic tools to market that promise better results for cancer patients through the identification of mutations in cancer cells that can create more targeted therapies. Earlier this month, research using technology developed by the startup Mission Bio helped identify cellular mutations in acute myeloid leukemia cancer cells that could […]
View More Companies tracking mutations in cancer cells can provide a key to unlocking better therapiesChina’s Infervision is helping 280 hospitals worldwide detect cancers from images
Until recently, humans have relied on the trained eyes of doctors to diagnose diseases from medical images. Beijing-based Infervision is among a handful of artificial intelligence startups around the world racing to improve medical imaging analysis through deep learning, the same technology that powers face recognition and autonomous driving. The startup, which has to date raised $70 […]
View More China’s Infervision is helping 280 hospitals worldwide detect cancers from imagesAirport security bins are gross as hell, according to a new study
Surprisingly, the toilet seat isn’t the dirtiest part of an airport. Neither is the bathroom door handle, or the baggage claim, or even the floor.
Germs love the plastic security trays, according to a study from the University of Nottingham and…
RDMD attacks rare diseases with data mined from health records
You wouldn’t expect a medical app to get its start as a Snapchat competitor. Neither did video chat startup TapTalk’s founder Onno Faber. But four years ago he was diagnosed with a rare disease called Neurofibromatosis Type 2 that caused tumors leading Onno to lose hearing in one ear. He’s amongst the one in ten people with […]
View More RDMD attacks rare diseases with data mined from health recordsResearchers create the first 3D-printed corneas
Researchers at Newcastle University have been able to 3D-print a biocompatible corneal framework using a new gel formulations that “keeps the stem cells alive whilst producing a material which is stiff enough to hold its shape but soft enough to be squeezed out the nozzle of a 3D printer.” There is a significant shortage of […]
View More Researchers create the first 3D-printed corneasToward transitive data privacy and securing the data you don’t share
Anshu Sharma Contributor Anshu Sharma is a serial entrepreneur and a former venture partner at Storm Ventures. More posts by this contributor The unbeatable advantage of Apple and Amazon An engineer’s guide to picking a startup We are spending a lot of time discussing what happens to data when you explicitly or implicitly share it. […]
View More Toward transitive data privacy and securing the data you don’t shareMammoth Biosciences launches a CRISPR-powered search engine for disease detection
Most people tend to think of CRISPR as a groundbreaking gene-editing technology that can hunt down and snip away bits of DNA, like the cut and paste function on a keyboard. While many research projects tend to emphasize the potential of that process in replacing target bits of genetic material, for Mammoth Biosciences, the search […]
View More Mammoth Biosciences launches a CRISPR-powered search engine for disease detection